509 related articles for article (PubMed ID: 19422483)
1. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
[TBL] [Abstract][Full Text] [Related]
2. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
Savvidou S; Hytiroglou P; Orfanou-Koumerkeridou H; Panderis A; Frantzoulis P; Goulis J
J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862
[TBL] [Abstract][Full Text] [Related]
3. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
Krawczyk K; Szczesniak P; Kumor A; Jasinska A; Omulecka A; Pietruczuk M; Orszulak-Michalak D; Sporny S; Malecka-Panas E
J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485
[TBL] [Abstract][Full Text] [Related]
4. Beyond insulin resistance in NASH: TNF-alpha or adiponectin?
Hui JM; Hodge A; Farrell GC; Kench JG; Kriketos A; George J
Hepatology; 2004 Jul; 40(1):46-54. PubMed ID: 15239085
[TBL] [Abstract][Full Text] [Related]
5. Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese.
Wong VW; Wong GL; Yu J; Choi PC; Chan AW; Chan HY; Chu ES; Cheng AS; Chim AM; Chan FK; Sung JJ; Chan HL
Am J Gastroenterol; 2010 Jan; 105(1):132-8. PubMed ID: 19809411
[TBL] [Abstract][Full Text] [Related]
6. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?
Chitturi S; Farrell G; Frost L; Kriketos A; Lin R; Fung C; Liddle C; Samarasinghe D; George J
Hepatology; 2002 Aug; 36(2):403-9. PubMed ID: 12143049
[TBL] [Abstract][Full Text] [Related]
7. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Rodella S; Zoppini G; Scala L; Zenari L; Falezza G
Clin Endocrinol (Oxf); 2006 Jun; 64(6):679-83. PubMed ID: 16712671
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis.
Tiftikci A; Atug O; Yilmaz Y; Eren F; Ozdemir FT; Yapali S; Ozdogan O; Celikel CA; Imeryuz N; Tozun N
Arch Med Res; 2009 May; 40(4):294-8. PubMed ID: 19608019
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease].
Kim KO; Park SH; Park CH; Han TH; Yoo KS; Kim JH; Lee MS; Kim DJ; Park CK; Cho HD
Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885
[TBL] [Abstract][Full Text] [Related]
10. The relationship between serum adiponectin and steatosis in patients with chronic hepatitis C genotype-4.
Ashour E; Samy N; Sayed M; Imam A
Clin Lab; 2010; 56(3-4):103-10. PubMed ID: 20476641
[TBL] [Abstract][Full Text] [Related]
11. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
12. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.
Wong VW; Wong GL; Choi PC; Chan AW; Li MK; Chan HY; Chim AM; Yu J; Sung JJ; Chan HL
Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244
[TBL] [Abstract][Full Text] [Related]
13. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
[TBL] [Abstract][Full Text] [Related]
14. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.
Giannini E; Botta F; Cataldi A; Tenconi GL; Ceppa P; Barreca T; Testa R
Hepatogastroenterology; 1999; 46(28):2422-5. PubMed ID: 10522010
[TBL] [Abstract][Full Text] [Related]
15. Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia.
Inoue M; Yano M; Yamakado M; Maehata E; Suzuki S
Metabolism; 2006 Sep; 55(9):1248-54. PubMed ID: 16919546
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis.
Shimada M; Kawahara H; Ozaki K; Fukura M; Yano H; Tsuchishima M; Tsutsumi M; Takase S
Am J Gastroenterol; 2007 Sep; 102(9):1931-8. PubMed ID: 17511754
[TBL] [Abstract][Full Text] [Related]
17. [Fatty liver disease, insulin resistance and adiponectin in an obese pediatric population].
López-Capapé M; López-Bermejo A; Alonso Blanco M; Lara Orejas E; Corbatón Blasco J; Barrio Castellanos R
An Pediatr (Barc); 2009 Dec; 71(6):495-501. PubMed ID: 19850541
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and histological features of non-alcoholic fatty liver disease].
Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
[TBL] [Abstract][Full Text] [Related]
19. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
20. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease.
Musso G; Gambino R; Durazzo M; Biroli G; Carello M; Fagà E; Pacini G; De Michieli F; Rabbione L; Premoli A; Cassader M; Pagano G
Hepatology; 2005 Nov; 42(5):1175-83. PubMed ID: 16231364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
